Schedule 13D ownership disclosure
aTYR PHARMA INC
Security class unavailable · CUSIP: 002120103
Event date: 2019-04-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,619,114
- Percent of class
- 7.8900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001564590-19-011738
- Form type
- SC 13D
- Filer
- SCHIMMEL PAUL
- CIK
- CIK 1236447
- Filed
- Apr 16, 2019
- Reporting period
- Apr 12, 2019
- Description
- Schedule 13D beneficial ownership